Nanoform Finland (OHEL:NANOFH) Cash-to-Debt : 7.59 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Nanoform Finland Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Nanoform Finland's cash to debt ratio for the quarter that ended in Dec. 2023 was 7.59.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Nanoform Finland could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Nanoform Finland's Cash-to-Debt or its related term are showing as below:

OHEL:NANOFH' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.13 Med: 4.96 Max: 9.92
Current: 7.59

During the past 8 years, Nanoform Finland's highest Cash to Debt Ratio was 9.92. The lowest was 0.13. And the median was 4.96.

OHEL:NANOFH's Cash-to-Debt is ranked better than
50.94% of 1486 companies
in the Biotechnology industry
Industry Median: 6.9 vs OHEL:NANOFH: 7.59

Nanoform Finland Cash-to-Debt Historical Data

The historical data trend for Nanoform Finland's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Nanoform Finland Cash-to-Debt Chart

Nanoform Finland Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

1.99

8.88

9.88

9.92

7.59

Nanoform Finland Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															9.92	9.59	8.72	8.18	7.59

Competitive Comparison of Nanoform Finland's Cash-to-Debt

For the Biotechnology subindustry, Nanoform Finland's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nanoform Finland's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanoform Finland's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Nanoform Finland's Cash-to-Debt falls into.

Nanoform Finland Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Nanoform Finland's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	47.493	/	(1.054	+	5.203)
	=	7.59

Nanoform Finland's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	47.493	/	(1.054	+	5.203)
	=	7.59

Nanoform Finland (OHEL:NANOFH) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Nanoform Finland Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Nanoform Finland's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanoform Finland (OHEL:NANOFH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanoform Finland PLC (OHEL:NANOFH) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

NANOFS:Sweden 4YL:Germany

Address

Cultivator II, Viikinkaari 4, Helsinki, FIN, 00790

Website

https://www.nanoform.com

Nanoform Finland PLC is a nanoparticle medicine-enabling company. The company works together with pharma and biotech partners to reduce attrition in clinical trials and enhance their molecules' formulation performance through its nano-forming services. Its patented and scalable Controlled Expansion of Supercritical Solutions (CESS) technology produces nano-formed API particles as small as 10nm. This enables poorly soluble molecules in the pharmaceutical pipeline to progress into clinical development by increasing their rate of dissolution and by improving their bioavailability. Its technology provides novel opportunities in many value-enhancing drug delivery applications.

Nanoform Finland (OHEL:NANOFH) Headlines

No Headlines